• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials.严重无保护左主干冠状动脉疾病的经皮冠状动脉介入治疗或冠状动脉旁路移植术：解读NOBLE和EXCEL试验
J Thorac Dis. 2017 May;9(5):E451-E456. doi: 10.21037/jtd.2017.04.38.
2
Unprotected Left Main Coronary Artery Disease: Management in the Post NOBLE and EXCEL Era.无保护左主干冠状动脉疾病：NOBLE和EXCEL时代后的管理
Interv Cardiol. 2017 Sep;12(2):92-96. doi: 10.15420/icr.2017:18:2.
3
Generalizability of EXCEL and NOBLE results to a large registry population with unprotected left main coronary artery disease.EXCEL和NOBLE研究结果对大量无保护左主干冠状动脉疾病注册人群的可推广性。
Coron Artery Dis. 2017 Dec;28(8):675-682. doi: 10.1097/MCA.0000000000000543.
4
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄。
Curr Cardiol Rep. 2019 Mar 18;21(5):27. doi: 10.1007/s11886-019-1113-0.
5
Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.男性和女性无保护左主干病变患者行冠状动脉支架置入术或旁路手术的结果：EXCEL 试验。
JACC Cardiovasc Interv. 2018 Jul 9;11(13):1234-1243. doi: 10.1016/j.jcin.2018.03.051.
6
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄：NOBLE 随机非劣效性试验的 5 年更新结果。
Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23.
7
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
8
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.左主干病变经依维莫司洗脱支架或旁路手术后的生活质量：EXCEL 试验结果。
J Am Coll Cardiol. 2017 Dec 26;70(25):3113-3122. doi: 10.1016/j.jacc.2017.10.036. Epub 2017 Oct 30.
9
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.EXCEL 试验中依维莫司洗脱支架与冠状动脉旁路移植术治疗左主干血运重建效果的长期预测和死亡率比较：SYNTAX 评分 II 的前瞻性验证。
Eur Heart J. 2015 May 21;36(20):1231-41. doi: 10.1093/eurheartj/ehu518. Epub 2015 Jan 12.
10
Percutaneous coronary intervention in left main disease: SYNTAX, PRECOMBAT, EXCEL and NOBLE-combined cardiology and cardiac surgery perspective.左主干病变的经皮冠状动脉介入治疗：SYNTAX、PRECOMBAT、EXCEL和NOBLE——心脏病学与心脏外科学联合视角
Ann Cardiothorac Surg. 2018 Jul;7(4):521-526. doi: 10.21037/acs.2018.04.04.

引用本文的文献

1
Research and application of KABP nursing model in cardiac rehabilitation of patients with acute myocardial infarction after PCI.KABP护理模式在PCI术后急性心肌梗死患者心脏康复中的研究与应用
Am J Transl Res. 2021 Apr 15;13(4):3022-3033. eCollection 2021.
2
Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative.当代美国无保护左主干冠状动脉经皮冠状动脉介入治疗的应用和趋势：国家心血管数据注册研究实践倡议分析。
JAMA Cardiol. 2019 Feb 1;4(2):100-109. doi: 10.1001/jamacardio.2018.4376.

本文引用的文献

1
Stents versus bypass surgery for left main stem stenosis - Authors' reply.
Lancet. 2017 Apr 22;389(10079):1609. doi: 10.1016/S0140-6736(17)31022-X.
2
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.依维莫司洗脱支架与冠状动脉搭桥手术治疗左主干冠状动脉疾病
N Engl J Med. 2017 Mar 16;376(11):1087-8. doi: 10.1056/NEJMc1701177.
3
Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.左主干冠状动脉疾病：患者特征、治疗方法和预后的长期变化趋势。
J Am Coll Cardiol. 2016 Sep 13;68(11):1233-1246. doi: 10.1016/j.jacc.2016.05.089.
4
Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials.药物洗脱支架和生物可吸收支架的支架内血栓形成：来自 147 项试验的网络荟萃分析证据。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1203-1212. doi: 10.1016/j.jcin.2016.03.038. Epub 2016 Jun 1.
5
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的冠状动脉搭桥手术
N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3.
6
Everolimus-eluting stents or bypass surgery for multivessel coronary disease.依维莫司洗脱支架或旁路手术治疗多支冠状动脉疾病。
N Engl J Med. 2015 Mar 26;372(13):1213-22. doi: 10.1056/NEJMoa1412168. Epub 2015 Mar 16.
7
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2014年美国心脏病学会/美国心脏协会/美国胸外科医师协会/预防心血管护士协会/心血管造影和介入学会/胸外科医师学会对稳定型缺血性心脏病患者诊断和管理指南的重点更新：美国心脏病学会/美国心脏协会实践指南工作组、美国胸外科医师协会、预防心血管护士协会、心血管造影和介入学会及胸外科医师学会的报告
J Am Coll Cardiol. 2014 Nov 4;64(18):1929-49. doi: 10.1016/j.jacc.2014.07.017. Epub 2014 Jul 28.
8
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.在紫杉醇药物涂层支架与心脏搭桥术联合治疗左主干病变研究中，经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗左主干病变患者的 5 年结果。
Circulation. 2014 Jun 10;129(23):2388-94. doi: 10.1161/CIRCULATIONAHA.113.006689. Epub 2014 Apr 3.
9
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.药物洗脱支架置入治疗无保护左主干冠状动脉疾病后，冠状动脉解剖结构和支架技术对长期预后的影响。
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
10
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.冠状动脉疾病用裸金属支架、耐用聚合物药物洗脱支架和可生物降解聚合物药物洗脱支架：混合治疗比较荟萃分析。
BMJ. 2013 Nov 8;347:f6625. doi: 10.1136/bmj.f6625.

PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials.

作者信息

Holmes Anthony A, Bangalore Sripal

机构信息

Leon H. Charney Division of Cardiology, New York University Langone Medical Center, NYU School of Medicine, New York, NY, USA.

出版信息

J Thorac Dis. 2017 May;9(5):E451-E456. doi: 10.21037/jtd.2017.04.38.

DOI:10.21037/jtd.2017.04.38
PMID:28616307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5465155/
Abstract
摘要